Involvement of Brca2 in DNA repair.

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res (2012) 15.90

ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev (2000) 7.28

Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA (2011) 6.81

In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature (2000) 4.38

Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol Cell Biol (2001) 4.19

The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer (2010) 4.06

BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer (2011) 3.85

A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol Cell Biol (2003) 3.85

Comparative genomics and molecular dynamics of DNA repeats in eukaryotes. Microbiol Mol Biol Rev (2008) 3.35

Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. EMBO J (2001) 3.21

Deletion of Ku86 causes early onset of senescence in mice. Proc Natl Acad Sci U S A (1999) 2.97

Susceptibility pathways in Fanconi's anemia and breast cancer. N Engl J Med (2010) 2.79

Mechanisms of double-strand break repair in somatic mammalian cells. Biochem J (2009) 2.68

Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation. Genes Dev (2000) 2.47

Analysis of PALB2/FANCN-associated breast cancer families. Proc Natl Acad Sci U S A (2007) 2.41

Male sterility and enhanced radiation sensitivity in TLS(-/-) mice. EMBO J (2000) 2.05

Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein. Genes Dev (2003) 2.03

The BRCA2 gene product functionally interacts with p53 and RAD51. Proc Natl Acad Sci U S A (1998) 1.97

Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining. Proc Natl Acad Sci U S A (2001) 1.97

Rad52 inactivation is synthetically lethal with BRCA2 deficiency. Proc Natl Acad Sci U S A (2010) 1.94

Interaction with the BRCA2 C terminus protects RAD51-DNA filaments from disassembly by BRC repeats. Nat Struct Mol Biol (2007) 1.89

Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol Cell Biol (2003) 1.84

Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol Cell Biol (1999) 1.77

Fanconi anaemia. J Med Genet (2003) 1.70

A YY1-INO80 complex regulates genomic stability through homologous recombination-based repair. Nat Struct Mol Biol (2007) 1.68

A region of human BRCA2 containing multiple BRC repeats promotes RAD51-mediated strand exchange. Nucleic Acids Res (2006) 1.68

Mammalian Rif1 contributes to replication stress survival and homology-directed repair. J Cell Biol (2009) 1.66

BRCA1 and BRCA2: chemosensitivity, treatment outcomes and prognosis. Fam Cancer (2006) 1.65

Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J (2007) 1.65

The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers. BMC Cancer (2007) 1.63

Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response. Nat Rev Mol Cell Biol (2013) 1.62

Unraveling the mechanism of BRCA2 in homologous recombination. Nat Struct Mol Biol (2011) 1.59

An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. Nat Rev Cancer (2011) 1.58

Brca2 is involved in meiosis in Arabidopsis thaliana as suggested by its interaction with Dmc1. EMBO J (2004) 1.56

Homologous DNA recombination in vertebrate cells. Proc Natl Acad Sci U S A (2001) 1.52

Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks. DNA Repair (Amst) (2007) 1.52

Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice. Mol Cell Biol (1999) 1.50

Structural basis for recruitment of BRCA2 by PALB2. EMBO Rep (2009) 1.50

Making the best of PARP inhibitors in ovarian cancer. Nat Rev Clin Oncol (2010) 1.47

Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2. Nat Med (2008) 1.47

FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J (2002) 1.47

BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage. Mol Cell Biol (2004) 1.44

BRCA2 acts as a RAD51 loader to facilitate telomere replication and capping. Nat Struct Mol Biol (2010) 1.44

A Class of Environmental and Endogenous Toxins Induces BRCA2 Haploinsufficiency and Genome Instability. Cell (2017) 1.44

Replication stress and cancer. Nat Rev Cancer (2015) 1.43

When 2+2=5: the origins and fates of aneuploid and tetraploid cells. Biochim Biophys Acta (2008) 1.42

Similar effects of Brca2 truncation and Rad51 paralog deficiency on immunoglobulin V gene diversification in DT40 cells support an early role for Rad51 paralogs in homologous recombination. Mol Cell Biol (2005) 1.33

Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat Neurosci (2013) 1.31

Molecular analysis of sister chromatid recombination in mammalian cells. DNA Repair (Amst) (2005) 1.30

RAD51 localization and activation following DNA damage. Philos Trans R Soc Lond B Biol Sci (2004) 1.29

Pathology of hereditary breast cancer. Cell Oncol (Dordr) (2011) 1.28

Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function. Oncogene (2009) 1.25

BRCA2 is required for neurogenesis and suppression of medulloblastoma. EMBO J (2007) 1.21

Trypanosoma brucei BRCA2 acts in antigenic variation and has undergone a recent expansion in BRC repeat number that is important during homologous recombination. Mol Microbiol (2008) 1.15

Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity. Hum Mutat (2010) 1.13

Drosophila brca2 is required for mitotic and meiotic DNA repair and efficient activation of the meiotic recombination checkpoint. PLoS Genet (2008) 1.13

Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3. Br J Cancer (1999) 1.06

Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas. Clin Cancer Res (2008) 1.06

Understanding cytokinesis failure. Adv Exp Med Biol (2010) 1.06

Rad51 overexpression rescues radiation resistance in BRCA2-defective cancer cells. Mol Carcinog (2009) 1.04

Deubiquitylating enzymes and DNA damage response pathways. Cell Biochem Biophys (2013) 1.03

Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation. Cancer Res (2009) 1.02

RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer. Carcinogenesis (2010) 1.02

A syngeneic variance library for functional annotation of human variation: application to BRCA2. Cancer Res (2008) 1.02

BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers. Br J Cancer (2009) 1.00

Cell cycle-dependent induction of homologous recombination by a tightly regulated I-SceI fusion protein. PLoS One (2011) 0.99

Distinct functions of BRCA1 and BRCA2 in double-strand break repair. Breast Cancer Res (2001) 0.98

DNA-binding Domain within the Brh2 N Terminus Is the Primary Interaction Site for Association with DNA. J Biol Chem (2009) 0.98

BRCA1, BRCA2 and their possible function in DNA damage response. Br J Cancer (1999) 0.96

Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility. J Biol Chem (2011) 0.95

Role of BRCA gene dysfunction in breast and ovarian cancer predisposition. Breast Cancer Res (2000) 0.94

Functional assays for analysis of variants of uncertain significance in BRCA2. Hum Mutat (2013) 0.92

Tumor hypoxia as a driving force in genetic instability. Genome Integr (2013) 0.92

Interplay between Fanconi anemia and homologous recombination pathways in genome integrity. EMBO J (2016) 0.92

Homologous Recombination and Its Role in Carcinogenesis. J Biomed Biotechnol (2002) 0.91

Caretaker Brca1: keeping the genome in the straight and narrow. Breast Cancer Res (2000) 0.91

Mutator phenotype of Caenorhabditis elegans DNA damage checkpoint mutants. Genetics (2006) 0.90

Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism. Breast Cancer Res (2007) 0.89

Interrogation of the protein-protein interactions between human BRCA2 BRC repeats and RAD51 reveals atomistic determinants of affinity. PLoS Comput Biol (2011) 0.88

Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression. Breast Cancer Res (2011) 0.88

Ortholog of BRCA2-interacting protein BCCIP controls morphogenetic responses during DNA replication stress in Ustilago maydis. DNA Repair (Amst) (2007) 0.88

The breast cancer susceptibility gene BRCA2 is required for the maintenance of telomere homeostasis. J Biol Chem (2011) 0.88

DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. PLoS Genet (2014) 0.88

Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis. PLoS Genet (2010) 0.88

The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers. Front Biosci (Landmark Ed) (2014) 0.88

Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay. Hum Mol Genet (2012) 0.88

BRCA2 suppresses cell proliferation via stabilizing MAGE-D1. Cancer Res (2005) 0.87

Context dependence of checkpoint kinase 1 as a therapeutic target for pancreatic cancers deficient in the BRCA2 tumor suppressor. Mol Cancer Ther (2011) 0.87

Predictive modeling using a somatic mutational profile in ovarian high grade serous carcinoma. PLoS One (2013) 0.87

Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review. Int J Surg Oncol (2011) 0.86

A mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressor. Oncogene (2011) 0.86

Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2. Proc Natl Acad Sci U S A (2010) 0.86

Homologs of breast cancer genes in plants. Front Plant Sci (2011) 0.86

Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in mice. PLoS One (2013) 0.85

CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status. Br J Cancer (2003) 0.85

Transgenic and knockout mice models to reveal the functions of tumor suppressor genes. Clin Med Insights Oncol (2011) 0.85

The breast cancer susceptibility gene, BRCA2: at the crossroads between DNA replication and recombination? Philos Trans R Soc Lond B Biol Sci (2000) 0.84

Small-molecule inhibitors of DNA damage-repair pathways: an approach to overcome tumor resistance to alkylating anticancer drugs. Future Med Chem (2012) 0.83

BRCA2 and homologous recombination. Breast Cancer Res (2001) 0.83

Non-homologous end joining, but not homologous recombination, enables survival for cells exposed to a histone deacetylase inhibitor. Nucleic Acids Res (2005) 0.82

Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 30.49

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09

Complete genome sequence of Methanobacterium thermoautotrophicum deltaH: functional analysis and comparative genomics. J Bacteriol (1997) 12.21

Role of the INK4a locus in tumor suppression and cell mortality. Cell (1996) 11.41

Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics (1992) 9.06

NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet (2000) 7.98

College binge drinking in the 1990s: a continuing problem. Results of the Harvard School of Public Health 1999 College Alcohol Study. J Am Coll Health (2000) 7.87

The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins. Mol Cell Biol (1995) 6.99

Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06

Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction. J Clin Microbiol (1994) 5.61

Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol Cell (2001) 5.59

Hemoglobin messenger ribonucleic acid. Synthesis of 9S and ribosomal ribonucleic acid during erythroid cell development. Biochemistry (1969) 5.37

Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc Natl Acad Sci U S A (1975) 4.95

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet (1995) 4.86

Increased levels of cigarette use among college students: a cause for national concern. JAMA (1998) 4.85

The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell (1994) 4.58

Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer (1997) 4.47

Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet (1997) 4.16

Open-reading-frame sequence tags (OSTs) support the existence of at least 17,300 genes in C. elegans. Nat Genet (2001) 4.03

Changes in binge drinking and related problems among American college students between 1993 and 1997. Results of the Harvard School of Public Health College Alcohol Study. J Am Coll Health (1998) 4.03

Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis (1994) 3.93

An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet (1995) 3.81

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N Engl J Med (1998) 3.60

Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet (1996) 3.53

Eomesodermin is required for mouse trophoblast development and mesoderm formation. Nature (2000) 3.53

Bicycle accidents in childhood. Br Med J (Clin Res Ed) (1987) 3.51

Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic. J Clin Microbiol (1995) 3.47

The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa. J Gen Microbiol (1989) 3.45

Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol (2001) 3.35

A clonal marker induced by mutation in mouse intestinal epithelium. Nature (1988) 3.35

Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature (1994) 3.33

The Arabidopsis LOS5/ABA3 locus encodes a molybdenum cofactor sulfurase and modulates cold stress- and osmotic stress-responsive gene expression. Plant Cell (2001) 3.26

Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet (1992) 3.13

Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J Neurosci (2000) 3.10

Assignment of the membrane attachment, DNA binding, and transcriptional activation domains of sterol regulatory element-binding protein-1 (SREBP-1). J Biol Chem (1994) 3.09

Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2. Exp Mol Pathol (1975) 3.07

Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect (2006) 3.04

Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosomes Cancer (1992) 3.03

Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med (2000) 3.00

Development of the pattern of cell renewal in the crypt-villus unit of chimaeric mouse small intestine. Development (1988) 2.97

CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev (1998) 2.91

Mutations truncating the EP300 acetylase in human cancers. Nat Genet (2000) 2.84

Renewal of alveolar epithelium in the rat following exposure to NO2. Am J Pathol (1973) 2.80

An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet (1993) 2.79

Risk models for familial ovarian and breast cancer. Genet Epidemiol (2000) 2.75

FIERY1 encoding an inositol polyphosphate 1-phosphatase is a negative regulator of abscisic acid and stress signaling in Arabidopsis. Genes Dev (2001) 2.73

Height and surfacing as risk factors for injury in falls from playground equipment: a case-control study. Inj Prev (1996) 2.71

Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J (1996) 2.68

The relationship between tobacco access and use among adolescents: a four community study. Soc Sci Med (1999) 2.64

Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs. J Clin Microbiol (1995) 2.62

Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J Virol (1997) 2.57

Increased use of marijuana and other illicit drugs at US colleges in the 1990s: results of three national surveys. Addiction (2000) 2.57

Extent of microstructural white matter injury in postconcussive syndrome correlates with impaired cognitive reaction time: a 3T diffusion tensor imaging study of mild traumatic brain injury. AJNR Am J Neuroradiol (2008) 2.55

DNA "fingerprints" and segregation analysis of multiple markers in human pedigrees. Am J Hum Genet (1986) 2.55

Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs. Nature (1994) 2.54

Familial breast cancer. BMJ (1994) 2.54

Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet (1997) 2.53

DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet (2001) 2.50

Detection of Chlamydia trachomatis infection in urine samples from men and women by ligase chain reaction. J Clin Microbiol (1995) 2.50

Fate of teratocarcinoma cells injected into early mouse embryos. Nature (1975) 2.48

Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation. Genes Dev (2000) 2.47

HOS1, a genetic locus involved in cold-responsive gene expression in arabidopsis. Plant Cell (1998) 2.47

Identification of a protein binding site on the surface of the alphavirus nucleocapsid and its implication in virus assembly. Structure (1996) 2.46

Instability of short tandem repeats (microsatellites) in human cancers. Nat Genet (1994) 2.45

Acupuncture for pain relief in labour: a systematic review and meta-analysis. BJOG (2010) 2.43

Role of the Clara cell in renewal of the bronchiolar epithelium. Lab Invest (1978) 2.42

Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA (1994) 2.40

A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev (1999) 2.39

Familial gastric cancer: overview and guidelines for management. J Med Genet (1999) 2.38

THRA1 and D17S183 flank an interval of < 4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21. Am J Hum Genet (1993) 2.37

Stage-specific embryonic antigen involves alpha 1 goes to 3 fucosylated type 2 blood group chains. Nature (1981) 2.35

A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature (1987) 2.33

Derivation of mouse intestinal crypts from single progenitor cells. Nature (1985) 2.31

Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA (1983) 2.29

Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature (1998) 2.29

Irritable bowel syndrome. N Engl J Med (1993) 2.28

Deletion of genes on chromosome 1 in endocrine neoplasia. Nature (1987) 2.27

Jasmonic acid signaling modulates ozone-induced hypersensitive cell death. Plant Cell (2000) 2.27

Local bone mineral response to brief exercise that stresses the skeleton. BMJ (1989) 2.25

Presenilin-mediated modulation of capacitative calcium entry. Neuron (2000) 2.25

Environmental correlates of underage alcohol use and related problems of college students. Am J Prev Med (2000) 2.23

The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study. Br J Dermatol (2011) 2.22

Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res (1998) 2.20

Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature (1998) 2.19

The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development (1991) 2.17

Comparison of DNA amplification methods for the detection of Chlamydia trachomatis in first-void urine from asymptomatic military recruits. Sex Transm Dis (1997) 2.15

Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group. Neurology (1999) 2.14

Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone. Am J Med (1991) 2.14

The nuclear location signal. Proc R Soc Lond B Biol Sci (1985) 2.14

Prevalence of diabetes and IGT in Yonchon County, South Korea. Diabetes Care (1995) 2.11

NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am J Med Genet (1998) 2.09

Are there sex differences in neuropsychological functions among patients with schizophrenia? Am J Psychiatry (1998) 2.08

Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry (1999) 2.04

Effect of 2',3'-dideoxythymidine-5'-triphosphate on HeLa cell in vitro DNA synthesis: evidence that DNA polymerase alpha is the only polymerase required for cellular DNA replication. Nucleic Acids Res (1978) 2.04

Transfusion transmission of human T-lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look-back investigations. Transfusion (1993) 2.03

The extent of linkage disequilibrium in four populations with distinct demographic histories. Am J Hum Genet (2000) 2.03